Contact

All Stories

  1. Human Cyclophilin B Nuclease Activity Revealed via Nucleic Acid‐Based Electrochemical Sensors

    Article • Angewandte Chemie International Edition, August 2022, Wiley

    Dr. Partha Ray

  2. Bioengineering strategy to develop high-affinity SARS CoV-2 Spike protein binding ligands.

    Article • Protein Science, May 2022, Wiley

    Dr. Partha Ray

  3. Oxaliplatin-induced peripheral neuropathy can be minimized by pressurized regional intravascular delivery in an orthotopic murine pancreatic cancer model

    Article • Discover Oncology, April 2022, Springer Science + Business Media

    Dr. Partha Ray

  4. Dataset on optimization and development of a point-of-care glucometer-based SARS-CoV-2 detection assay using aptamers

    Article • Data in Brief, October 2021, Elsevier

    Dr. Partha Ray

  5. Development of a Soluble KIT Electrochemical Aptasensor for Cancer Theranostics

    Article • ACS Sensors, May 2021, American Chemical Society (ACS)

    Dr. Partha Ray

  6. An aptamer-based magnetic flow cytometer using matched filtering

    Article • Biosensors and Bioelectronics, December 2020, Elsevier

    Dr. Partha Ray

  7. Pressure-enabled delivery of gemcitabine in an orthotopic pancreatic cancer mouse model

    Article • Surgery, September 2020, Elsevier

    Dr. Partha Ray

  8. Anti-KIT DNA Aptamer for Targeted Labeling of Gastrointestinal Stromal Tumor

    Article • Molecular Cancer Therapeutics, May 2020, American Association for Cancer Research (AACR)

    Dr. Partha Ray

  9. Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model

    Article • Cancer Immunology Research, October 2019, American Association for Cancer Research (AACR)

    Dr. Partha Ray

  10. A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation

    Article • Journal of Visualized Experiments, June 2018, MyJove Corporation

    Dr. Partha Ray

  11. Cell-SELEX Identifies a “Sticky” RNA Aptamer Sequence

    Article • Journal of Nucleic Acids, January 2017, Hindawi Publishing Corporation

    Dr. Partha Ray

  12. In Vivo Selection Against Human Colorectal Cancer Xenografts Identifies an Aptamer That Targets RNA Helicase Protein DHX9

    Article • Molecular Therapy — Nucleic Acids, January 2016, Elsevier

    Dr. Partha Ray

  13. Further Characterization of the Target of a Potential Aptamer Biomarker for Pancreatic Cancer: Cyclophilin B and Its Posttranslational Modifications

    Article • Nucleic Acid Therapeutics, December 2013, Mary Ann Liebert Inc

    Dr. Partha Ray

  14. Application of Aptamers for Targeted Therapeutics

    Article • Archivum Immunologiae et Therapiae Experimentalis, April 2013, Springer Science + Business Media

    Dr. Partha Ray

  15. Aptamer-Mediated Delivery of Chemotherapy to Pancreatic Cancer Cells

    Article • Nucleic Acid Therapeutics, October 2012, Mary Ann Liebert Inc

    Dr. Partha Ray

  16. Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin B as a candidate pancreatic cancer biomarker

    Article • Journal of Clinical Investigation, May 2012, American Society for Clinical Investigation

    Dr. Partha Ray

  17. Aptamers for Targeted Drug Delivery

    Article • Pharmaceuticals, May 2010, MDPI AG

    Dr. Partha Ray

  18. The Saccharomyces cerevisiae 60 S Ribosome Biogenesis Factor Tif6p Is Regulated by Hrr25p-mediated Phosphorylation

    Article • Journal of Biological Chemistry, April 2008, Elsevier

    Dr. Partha Ray

  19. Activation of S phase checkpoint by cigarette smoke extract inSchizosaccharomyces pombe

    Article • Yeast, November 2005, Wiley

    Dr. Partha Ray